Harano, K., Fossati, R., Pardo, B., Galli, F., Hudson, E., Antill, Y., . . . Colombo, N. (2025). Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: The Asian cohort of the AtTEnd/ENGOT-EN7 trial.
Citação norma ChicagoHarano, Kenichi, et al. Phase III Double-blind Randomized Placebo Controlled Trial of Atezolizumab in Combination With Carboplatin and Paclitaxel in Women With Advanced/recurrent Endometrial Carcinoma: The Asian Cohort of the AtTEnd/ENGOT-EN7 Trial. 2025.
Citação norma MLAHarano, Kenichi, et al. Phase III Double-blind Randomized Placebo Controlled Trial of Atezolizumab in Combination With Carboplatin and Paclitaxel in Women With Advanced/recurrent Endometrial Carcinoma: The Asian Cohort of the AtTEnd/ENGOT-EN7 Trial. 2025.